Correlation Between Inhibikase Therapeutics and GlaxoSmithKline PLC
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and GlaxoSmithKline PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and GlaxoSmithKline PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and GlaxoSmithKline PLC ADR, you can compare the effects of market volatilities on Inhibikase Therapeutics and GlaxoSmithKline PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of GlaxoSmithKline PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and GlaxoSmithKline PLC.
Diversification Opportunities for Inhibikase Therapeutics and GlaxoSmithKline PLC
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inhibikase and GlaxoSmithKline is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and GlaxoSmithKline PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlaxoSmithKline PLC ADR and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with GlaxoSmithKline PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlaxoSmithKline PLC ADR has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and GlaxoSmithKline PLC go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and GlaxoSmithKline PLC
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 4.67 times more return on investment than GlaxoSmithKline PLC. However, Inhibikase Therapeutics is 4.67 times more volatile than GlaxoSmithKline PLC ADR. It trades about 0.01 of its potential returns per unit of risk. GlaxoSmithKline PLC ADR is currently generating about -0.03 per unit of risk. If you would invest 272.00 in Inhibikase Therapeutics on November 3, 2024 and sell it today you would lose (80.00) from holding Inhibikase Therapeutics or give up 29.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. GlaxoSmithKline PLC ADR
Performance |
| Timeline |
| Inhibikase Therapeutics |
| GlaxoSmithKline PLC ADR |
Inhibikase Therapeutics and GlaxoSmithKline PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and GlaxoSmithKline PLC
The main advantage of trading using opposite Inhibikase Therapeutics and GlaxoSmithKline PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, GlaxoSmithKline PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlaxoSmithKline PLC will offset losses from the drop in GlaxoSmithKline PLC's long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |